Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 290

1.

Immunogenetic factors in beryllium sensitization and chronic beryllium disease.

Weston A, Snyder J, McCanlies EC, Schuler CR, Andrew ME, Kreiss K, Demchuk E.

Mutat Res. 2005 Dec 30;592(1-2):68-78. Epub 2005 Jul 27. Review.

PMID:
16054169
2.

Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review.

McCleskey TM, Buchner V, Field RW, Scott BL.

Rev Environ Health. 2009 Apr-Jun;24(2):75-115. Review.

PMID:
19658317
3.

The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.

McCanlies EC, Ensey JS, Schuler CR, Kreiss K, Weston A.

Am J Ind Med. 2004 Aug;46(2):95-103.

PMID:
15273960
4.

Immunology of chronic beryllium disease.

Samuel G, Maier LA.

Curr Opin Allergy Clin Immunol. 2008 Apr;8(2):126-34. doi: 10.1097/ACI.0b013e3282f824a4. Review.

PMID:
18317020
5.

Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.

Maier LA, McGrath DS, Sato H, Lympany P, Welsh K, Du Bois R, Silveira L, Fontenot AP, Sawyer RT, Wilcox E, Newman LS.

J Immunol. 2003 Dec 15;171(12):6910-8.

6.

HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.

Richeldi L, Sorrentino R, Saltini C.

Science. 1993 Oct 8;262(5131):242-4.

PMID:
8105536
7.

HLA-DPB1 and chronic beryllium disease: a HuGE review.

McCanlies EC, Kreiss K, Andrew M, Weston A.

Am J Epidemiol. 2003 Mar 1;157(5):388-98. Review.

PMID:
12615603
8.

Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.

Wang Z, White PS, Petrovic M, Tatum OL, Newman LS, Maier LA, Marrone BL.

J Immunol. 1999 Aug 1;163(3):1647-53.

9.

Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.

Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Fingerlin TE, Sato H, Newman LS, Maier LA.

Am J Respir Crit Care Med. 2011 Jun 15;183(12):1680-8. doi: 10.1164/rccm.201002-0254OC. Epub 2011 Mar 11.

10.

Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease.

Snyder JA, Demchuk E, McCanlies EC, Schuler CR, Kreiss K, Andrew ME, Frye BL, Ensey JS, Stanton ML, Weston A.

J R Soc Interface. 2008 Jul 6;5(24):749-58.

11.

Genetic and exposure risks for chronic beryllium disease.

Maier LA.

Clin Chest Med. 2002 Dec;23(4):827-39. Review.

PMID:
12516537
12.

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove.

Silveira LJ, McCanlies EC, Fingerlin TE, Van Dyke MV, Mroz MM, Strand M, Fontenot AP, Bowerman N, Dabelea DM, Schuler CR, Weston A, Maier LA.

J Immunol. 2012 Oct 15;189(8):4014-23. doi: 10.4049/jimmunol.1200798. Epub 2012 Sep 12.

13.

Major histocompatibility locus genetic markers of beryllium sensitization and disease.

Saltini C, Richeldi L, Losi M, Amicosante M, Voorter C, van den Berg-Loonen E, Dweik RA, Wiedemann HP, Deubner DC, Tinelli C.

Eur Respir J. 2001 Oct;18(4):677-84.

14.

HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease.

Lombardi G, Germain C, Uren J, Fiorillo MT, du Bois RM, Jones-Williams W, Saltini C, Sorrentino R, Lechler R.

J Immunol. 2001 Mar 1;166(5):3549-55.

15.

Beryllium sensitivity is linked to HLA-DP genotype.

Wang Z, Farris GM, Newman LS, Shou Y, Maier LA, Smith HN, Marrone BL.

Toxicology. 2001 Aug 13;165(1):27-38.

PMID:
11551429
16.

Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.

Fontenot AP, Torres M, Marshall WH, Newman LS, Kotzin BL.

Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12717-22.

17.

Genetic determinants of sensitivity to beryllium in mice.

Tarantino-Hutchison LM, Sorrentino C, Nadas A, Zhu Y, Rubin EM, Tinkle SS, Weston A, Gordon T.

J Immunotoxicol. 2009 Jun;6(2):130-5. doi: 10.1080/15476910902977399.

PMID:
19589099
18.

Genetic factors modify the risk of developing beryllium disease.

Tinkle SS, Weston A, Flint MS.

Semin Respir Crit Care Med. 2003 Apr;24(2):169-78.

PMID:
16088536
19.

Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity.

Rossman MD, Stubbs J, Lee CW, Argyris E, Magira E, Monos D.

Am J Respir Crit Care Med. 2002 Mar 15;165(6):788-94.

PMID:
11897645
20.

HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.

Rosenman KD, Rossman M, Hertzberg V, Reilly MJ, Rice C, Kanterakis E, Monos D.

Occup Environ Med. 2011 Jul;68(7):487-93. doi: 10.1136/oem.2010.055046. Epub 2010 Dec 23. Review.

PMID:
21186201

Supplemental Content

Support Center